Clinical Trial Update: A Study of Acute Respiratory Infections in Global Outpatient Setting [EARLY_Phase 1]

View source ↗

Summary

An early-phase Phase 1 trial by Janssen in global outpatient settings evaluating Acute Respiratory Infection has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Infection

Snippet

Sponsor: Janssen Research & Development, LLC | Conditions: Acute Respiratory Infection | EARLY_Phase 1 | Status: COMPLETED